If you work in the life sciences industry, GxP Trainings is not optional. It is a regulatory requirement — enforced by the FDA, EMA, MHRA, Health Canada, WHO, and every other major regulatory authority worldwide.
Yet “GxP Trainings” means different things to different people. A quality assurance manager in a pharmaceutical manufacturing facility has very different training obligations than a clinical research associate running trials for a biotech company. A warehouse manager at a pharmaceutical distributor needs different training than a validation engineer qualifying sterile manufacturing equipment.
This guide cuts through the complexity. It explains exactly what GxP Trainings guidelines require, how they differ across disciplines, GMP, GCP, GDP, GLP, what regulators look for during inspections, and how to build a training programme that is genuinely fit for purpose — not just a compliance checkbox.
Why GxP Trainings Guidelines Exist
GxP Trainings requirements are not bureaucratic box-ticking. They exist because inadequately trained personnel are a direct risk to patient safety and product quality.
History has repeatedly shown what happens when pharmaceutical professionals do not understand — or do not apply — GxP principles:
- Contaminated drug products reaching patients
- Falsified clinical trial data influencing drug approvals
- Temperature excursions in cold chain distribution destroying product integrity
- Data integrity failures leading to recalled products and criminal investigations
Every major regulatory authority has concluded the same thing: documented, assessed, role-specific training is one of the most fundamental controls in any GxP system.
That is why training requirements appear in virtually every GxP regulation and guideline:
- FDA 21 CFR Part 211.25 — Personnel qualifications in pharmaceutical manufacturing
- EU GMP EudraLex Volume 4, Chapter 2 — Personnel training requirements
- ICH E6(R3) — GCP training for clinical trial personnel
- WHO GMP guidelines — Training requirements for manufacturing staff
- EU GDP Guidelines 2013/C 68/01 — GDP training for distribution personnel
The Core Principle: Training Must Be Documented
Across all GxP disciplines, one principle is non-negotiable:
Training must be documented. A verbal briefing is not sufficient.
FDA investigators, EMA inspectors, and Health Canada assessors will ask to see training records during every inspection. If you cannot produce documented evidence that a person was trained — with a date, content, and assessment result — the training effectively did not happen from a regulatory perspective.
This requirement exists because documentation is the only way to:
- Verify that training actually occurred
- Demonstrate consistency across a workforce
- Identify gaps when roles or regulations change
- Provide accountability when deviations or failures occur
Every training event in a GxP environment must generate a record that shows:
- Who was trained: full name and job title
- What they were trained on: SOP number/version, course title, guideline
- When the training occurred: date
- How the training was delivered: classroom, online, on-the-job demonstration
- Whether competency was assessed: pass/fail, score
- Who delivered or assessed the training
GxP Trainings Requirements by Discipline
GMP Training Requirements, Manufacturing
Regulatory basis: FDA 21 CFR Part 211.25 / EU GMP EudraLex Volume 4 Chapter 2 / ICH Q7 / WHO GMP
GMP Trainings is required for all personnel whose activities could affect the quality of a pharmaceutical product. This is the broadest GxP Trainings requirement and applies to the largest number of people in a typical pharmaceutical organisation.
Who must be trained:
- Production operators and supervisors
- QA and QC personnel
- Engineering, maintenance, and calibration staff
- Warehouse and materials management personnel
- Regulatory affairs professionals
What GMP training must cover:
Under FDA 21 CFR Part 211.25, personnel must have the education, training, and experience to perform their assigned functions. Training must include:
- The specific operations they perform
- Current Good Manufacturing Practice regulations as they relate to their functions
- Written procedures required by cGMP regulations
EU GMP, EudraLex Volume 4, Chapter 2, adds:
- Initial and continuing training relevant to each person’s tasks
- Training effectiveness must be assessed
- Training records must be maintained
Minimum GMP training programme:
| Training Element | Frequency | Audience |
| GMP principles and regulatory overview | On joining + annual refresher | All GMP personnel |
| Job-specific SOPs | Before performing activity + when SOPs are updated | Role-specific |
| Data integrity and documentation | On joining + annual | All GMP personnel |
| Hygiene and contamination control | On joining + annual | Manufacturing and QC |
| Deviation and CAPA procedures | On joining + when system changes | QA, production supervisors |
| Equipment-specific operation | Before using equipment | Operators |
GCP Training Requirements, Clinical Trials
Regulatory basis: ICH E6(R3) — updated 2025 / FDA 21 CFR Part 312 / EU CTR 536/2014
GCP Trainings is required for all personnel involved in the design, conduct, monitoring, recording, and reporting of clinical trials.
Who must be trained:
- Investigators and sub-investigators at clinical trial sites
- Clinical Research Associates, CRAs, and monitors
- Sponsor clinical operations and data management teams
- Contract Research Organisation, CRO, personnel
- Data managers, biostatisticians, and medical writers involved in clinical data
What GCP training must cover:
ICH E6(R3), the most current version, significantly updated in 2025, requires that all individuals involved in conducting a trial should be qualified by education, training, and experience to perform their respective tasks.
Core GCP training content:
- ICH E6(R3) principles and updates, particularly the 2025 revision
- Informed consent procedures and participant rights
- Investigator and sponsor responsibilities
- Protocol adherence and deviation management
- Trial Master File, TMF, requirements
- Risk-based monitoring and decentralised clinical trial, DCT, requirements
- Safety reporting obligations: SAEs, SUSARs
- Data integrity in electronic data capture, EDC, systems
Key 2025 ICH E6(R3) changes that require updated training:
- Expanded risk-based quality management, RBQM, framework
- New requirements for decentralised and hybrid clinical trials
- Updated data integrity and electronic records guidance
- Enhanced sponsor oversight obligations
For a full breakdown of ICH E6(R3) changes, see our guide: What is ICH E6(R3)? The 2025 GCP Update Explained
GDP Training Requirements, Distribution
Regulatory basis: EU GDP Guidelines 2013/C 68/01 / WHO GDP Guidelines / Health Canada GDP
GDP Trainings applies to all personnel involved in the wholesale distribution, storage, and transport of medicinal products.
Who must be trained:
- Warehouse managers and supervisors
- Picking, packing, and dispatch operatives
- Transport and logistics coordinators
- Responsible Persons, RPs — mandatory under EU GDP
- Purchasing and supplier qualification teams
- Cold chain and temperature monitoring specialists
What GDP training must cover:
EU GDP Guidelines state that personnel should receive initial and continuing training relevant to their role, based on written procedures and in accordance with a written training programme.
Core GDP training content:
- GDP regulatory framework: EU GDP Guidelines, WHO GDP, Health Canada
- Responsible Person, RP, obligations, EU
- Storage conditions and temperature requirements for pharmaceutical products
- Cold chain management and temperature excursion procedures
- Transport requirements for pharmaceutical products
- Falsified medicines detection and reporting
- Supplier qualification and approved supplier lists
- Documentation and record-keeping requirements
- Returns, recalls, and destruction procedures
GLP Training Requirements, Laboratory
Regulatory basis: OECD GLP Principles / FDA 21 CFR Part 58 / EU Directive 2004/10/EC
GLP Trainings applies to personnel involved in non-clinical safety studies — the laboratory tests conducted before a drug is tested in humans.
Who must be trained:
- Study Directors
- Principal Investigators
- Laboratory scientists and technicians
- QA unit personnel, GLP audit function
- Animal care personnel, for in vivo studies
What GLP training must cover:
- OECD GLP Principles and national GLP regulations
- Study plan and protocol requirements
- Standard Operating Procedures for laboratory operations
- Equipment calibration and maintenance
- Data recording and archiving
- Animal welfare, where applicable
- Study report requirements
For a full comparison of GLP and GMP requirements, see our guide: GLP vs GMP: Key Differences Explained
Building a GxP Trainings Programme — Step by Step
Step 1 — Define Your Training Matrix
A training matrix, also called a training needs analysis, maps every job role in your organisation to the specific training that role requires. It is the foundation of a structured GxP Trainings programme.
For each role, define:
- Mandatory initial training, must be completed before performing regulated activities
- Role-specific SOP training, the SOPs this role must read and be assessed on
- Annual refresher training requirements
- Any specialist training, such as equipment-specific or contamination control
The training matrix should be reviewed and updated whenever:
- A new role is created
- Job responsibilities change significantly
- New regulations or SOPs are introduced
Step 2 — Develop or Source Training Content
Training content must be relevant to the regulatory framework applicable to your organisation. There are two main approaches:
Internal training — SOPs, work instructions, and in-house presentations delivered by experienced personnel. Essential for job-specific procedures. Must be documented and assessed.
External training — Structured online or classroom courses from specialist GxP Trainings providers. Best for regulatory framework training, such as GMP principles, GCP fundamentals, and GDP requirements, because specialist providers maintain current, regulatory-aligned content.
When selecting an external GxP Trainings provider, look for:
- Content aligned with current regulations: FDA, EMA, ICH, WHO
- Self-paced online delivery that fits around operational schedules
- Assessment/quiz to verify knowledge
- Certificate that is 21 CFR Part 11 compliant and verifiable
- Recognition by regulatory authorities as valid training evidence
Step 3 — Deliver Training and Assess Competency
Training delivery is not just about information transfer — it must include assessment of competency. Regulators expect evidence that personnel understood and can apply what they were trained on.
Assessment methods by training type:
| Training Type | Appropriate Assessment |
| Online GxP course | Online quiz with pass mark, typically 70–80% |
| SOP training | Written or verbal confirmation of understanding |
| On-the-job training | Supervisor observation and sign-off |
| Equipment training | Demonstrated operation under supervision |
| GCP investigator training | Protocol-specific quiz + investigator meeting attendance |
Assessments must be scored, documented, and retained as training records.
Step 4 — Maintain Training Records
Training records are regulatory documents. They must be maintained with the same rigour as batch records, deviation logs, or clinical trial data.
Training record requirements:
- Stored in a controlled location, physical or electronic
- Accessible to QA and regulatory affairs
- Retained for the required period, typically the product lifecycle plus additional years per local regulations
- Protected from unauthorised alteration
- Available for regulatory inspection on request
Many organisations use a Learning Management System, LMS to manage training records electronically. LMS systems used for GxP Trainings records must comply with 21 CFR Part 11, FDA, or equivalent. Our Corporate GxP Trainings packages include a progress dashboard and centralised certificate management built for inspection readiness.
Step 5 — Manage Annual Refresher Training
GxP training is not a one-time event. Most regulatory frameworks require annual refresher training for all GxP personnel. Annual training serves to:
- Reinforce core GxP principles
- Update personnel on regulatory changes
- Address common deviations or inspection findings
- Ensure new personnel who joined during the year are included
Annual GxP refresher training should cover:
- Summary of any regulatory updates issued in the past 12 months
- Review of common internal deviation categories
- Data integrity refresher
- Any process or procedure changes implemented during the year
Step 6 — Update Training When Regulations Change
GxP regulations are not static. Major updates in recent years include:
- ICH E6(R3) — GCP guideline significantly revised in 2025. See our ICH E6(R3) guide
- EU GMP Annex 1 — Sterile manufacturing guideline revised in 2022/2023
- FDA Data Integrity Guidance — Multiple guidances published since 2018
- EU GDP Guidelines — Updated requirements for temperature control and falsified medicines
Whenever a significant regulatory update is issued, all relevant personnel must receive updated training — and that training must be documented.
What Regulators Look for During Training Inspections
When FDA, EMA, MHRA, or Health Canada inspectors review training during a GxP inspection, they typically examine:
1. Training records completeness
Are records present for all current personnel in GxP roles? Are there gaps — new starters who performed activities before completing training?
2. Training before activity
Can you demonstrate that personnel completed relevant training before performing regulated activities? Date comparisons between training records and batch records / clinical data are a common inspection technique.
3. SOP training currency
Are training records linked to current SOP versions? If an SOP was updated 6 months ago, was training completed on the new version?
4. Annual refresher compliance
Is there evidence of annual GxP refresher training for all relevant personnel in the past 12 months?
5. Training effectiveness
Were assessments completed? Were any personnel assessed as not competent? How were competency gaps addressed?
6. Corrective actions from training failures
If training failures or gaps were identified, were CAPAs raised and closed?
Common GxP Trainings Deficiencies and How to Avoid Them
| Deficiency | How to avoid it |
| No training records for a GxP activity | Implement training matrix — no activity without prior documented training |
| Training completed after the activity | Enforce the rule: training before activity, always |
| SOP training on outdated version | Link SOP training records to document version — retrain on every update |
| No annual refresher for existing staff | Schedule annual training in advance — calendar reminders, LMS alerts |
| Training records not accessible during inspection | Store records in a central, controlled, readily retrievable location |
| No competency assessment | Every training event must include a documented assessment |
| Generic training not role-specific | Use training matrix to ensure each person receives role-relevant training |
Frequently Asked Questions
Is online GxP Trainings accepted by regulatory authorities?
Yes. The FDA, EMA, MHRA, and WHO do not mandate classroom training. Online GxP Trainings is widely accepted provided it is content-appropriate, assessed, and documented. Certificates compliant with 21 CFR Part 11 are accepted as valid training records during inspections.
How often does GxP Trainings need to be renewed?
Most pharmaceutical organisations require annual GxP Trainings refresher as a minimum. Training must also be renewed when regulations change, when SOPs are updated, or when an employee’s role changes significantly.
What qualifies as a GxP Trainings record?
A GxP Trainings record must show: who was trained, on what topic/SOP/guideline, on what date, by what method, and with what assessed outcome. Electronic records must comply with 21 CFR Part 11 or equivalent.r equivalent.
Does GxP Trainings have to be classroom-based?
No. Online, e-learning, on-the-job training, and blended approaches are all acceptable provided they are documented and assessed. Online training is now the standard approach for regulatory framework training, including GMP principles, GCP guidelines, and GDP requirements.
Who is responsible for GxP Trainings in an organisation?
Typically, the QA department owns the GxP Trainings programme, works with HR on training records management, and coordinates with department managers on job-specific training delivery. Ultimately, senior management is accountable for ensuring adequate training resources are in place.
What happens if a GxP Trainings audit finds gaps?
Training gaps found during internal audits or regulatory inspections must be addressed through a formal CAPA — documenting the gap, the root cause, the corrective action taken, and the preventive action to stop recurrence. All affected personnel must complete remedial training, and the CAPA must be closed before the next inspection.
Conclusion
GxP Trainings guidelines are clear and consistent across all regulatory frameworks: training must be documented, role-specific, assessed, current, and readily retrievable. The specific content varies — GMP Trainings looks different from GCP Trainings, and both differ from GDP Trainings — but the underlying requirements are the same.
A well-designed GxP Trainings programme is not just a compliance exercise. It is the mechanism by which your organisation ensures that every person performing a regulated activity understands what is required, why it matters, and how to do it correctly. That understanding is what protects patients, maintains product quality, and keeps your organisation inspection-ready.
Build your GxP Trainings programme with GxP Trainings
Our online courses cover GMP, GCP, GDP, and EU GMP — aligned with FDA, EMA, ICH, and WHO guidelines. Self-paced. 21 CFR Part 11 compliant certificates. Accepted as valid training records during regulatory inspections.
Browse All GxP Training Courses
